Anova Enterprises, Inc. (Anova), a technology-enabled CRO dedicated to accelerating promising treatments, has announced enrollment of the first two pa ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

Researchers have been unable to find the original source in a Welsh Shigella outbreak that affected more than 50 people. In ...

Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction Press Release Date 03-11-2025 ...

SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for neurological disorders, today announced that the U.S. Food and Drug Administration ...

Q4 2024 Earnings Call Transcript March 20, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.24, ...

Despite its potential to transform the global economy and impact national security, quantum computing has advanced largely outside public ...

ATX-101 has completed a phase 1 study in patients with advanced solid tumours, showing preliminary evidence of efficacy and safety, and is currently in a phase 1b/2a trial in platinum-sensitive ...

Administered via intravitreal injection, Synthopsin-MCO-010 possesses a promoter to specifically target ON-bipolar cells.

See tolerance. Default is "2A" for UTS and "6g" for ISO. undersize amount to decrease screw diameter, a scalar to apply to all parts, or a 2-vector to control shaft and head. Replaces rather than ...